Typharm
Typharm is a family-owned UK life sciences group operating four subsidiaries that manufacture and supply specialty prescription and OTC pharmaceuticals across dermatology, digestive health, pain, and respiratory therapy areas, plus contract pharmaceutical packaging, primarily to the NHS, retailers, and export markets.
- Company typePrivate
- Founded1966
- HeadquartersNorwich, United Kingdom
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Typharm does
Typharm is a privately held, family-owned UK life sciences group headquartered in Norwich, England, organized into four operating subsidiaries: Typharm Limited and Amdeepcha Limited (both MHRA-licensed pharmaceutical manufacturers of prescription and OTC medicines), Packpharm Limited (an MHRA- and FDA-licensed contract packaging manufacturer), and Loyal Pharmacy Ltd (community pharmacy operator in Norfolk and Suffolk). The group develops, manufactures, and supplies specialty pharmaceuticals across seven therapy areas: dermatology and wound care, topical anti-inflammatory pain, paediatric and adult digestive health, fever and pain management, and respiratory health, with a former prostate cancer franchise (Staladex) divested in 2020.
The technical base centers on topical, oral liquid, suppository, and packaging formats produced in MHRA-approved facilities with controlled drugs and WDA(h) licensure. Products range from prescription-only medicines (Carbocisteine Syrup, Diclofenac Gel, Fludroxycortide Range, Nystaform Range) through pharmacy medicines (Docusate sodium, Paracetamol Suppositories) to GSL consumer products (Docusol Constipation Relief, Amgesic Pain Relief Gel). Packpharm additionally provides full-service pharmaceutical contract packaging, including US-bound assembly following 2023 FDA approval.
Revenue is generated across four streams: prescription product sales to the NHS and clinicians, OTC product sales through national and independent retailers plus online channels (Amazon, Chemist4U), contract manufacturing and packaging services via Packpharm, and retail pharmacy revenue from Loyal Pharmacy. Distribution is anchored in long-standing clinical relationships with NHS bodies, CCGs, hospital pharmacists, GPs, dermatologists, specialist nurses, and over twelve professional societies, with exports reaching the EU, Middle East, Asia, and the Caribbean. The group operates without external institutional or private equity ownership under Managing Director and practicing pharmacist Chandra Ondhia.
Typharm firmographics
Firmographics- Name
- Typharm
- Legal name
- Typharm Limited
- Website
- https://typharm.com
- Company type
- Private
- Founded year
- 1966
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Typharm is a family-owned UK life sciences group operating four subsidiaries that manufacture and supply specialty prescription and OTC pharmaceuticals across dermatology, digestive health, pain, and respiratory therapy areas, plus contract pharmaceutical packaging, primarily to the NHS, retailers, and export markets.
- Ownership category
- akta.pro rank
Typharm industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)
- akta.pro secondary industries
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Cold, Flu & Cough Remedies (HLAIADAB)
Keywords
Where Typharm is headquartered
LocationHeadquarters
- HQ city
- Norwich
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Typharm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Prescription Medicines: Prescription-only medicines (POM) including Carbocisteine Syrup, Diclofenac Gel, Fludroxycortide Range, Nystaform Range, and Staladex (Leuprorelin implant) for prostate cancer treatment.
- Over-the-Counter (OTC) Medicines: P Pharmacy medicines and GSL medicines sold through pharmacies and retailers including Docusate Sodium Range, Docusol products, Paracetamol Suppositories, and Vita-E Range.
- Manufacturing Services: Packaging medications for other companies, import and export of specialist medicines, and MHRA approved licensing solutions.
- Community Pharmacy: Loyal Pharmacy Ltd operates community pharmacies in Norfolk and Suffolk as part of the group structure.
Go-to-market motion2 records
Distribution channels7 records
Marketing channels5 records
Typharm product offering
Product offeringCore offering
Typharm is an MHRA-approved pharmaceutical manufacturer that develops, licenses, and supplies prescription-only medicines (POM) and over-the-counter (OTC) medicines across dermatology, wound care, digestive health, fever and pain, anti-inflammation, and respiratory health. Through its subsidiaries (Typharm Limited, Amdeepcha Limited, Packpharm Limited, and Loyal Pharmacy Ltd), the group produces its own branded and generic medicines, provides full-service contract medicine packaging, and operates community pharmacies in the UK with exports to the EU, Middle East, Asia, and the Caribbean.
Product overview
Typharm Group is a life sciences company founded in 1966, comprising four business units: Typharm Limited (prescription and OTC medicines focused on dermatology, wound care, digestive health), Amdeepcha Limited (pain, fever, inflammation, respiratory health), Loyal Pharmacy Ltd (community pharmacies), and Packpharm Limited (medicine packaging manufacturing). The company offers a portfolio of Prescription Only Medicines including Carbocisteine Syrup (respiratory), Diclofenac 1% Gel, Fludroxycortide Tape, Nystaform Range (dermatology), and Staladex (prostate cancer, divested). OTC products include Docusate Sodium Range and Docusol products (laxatives/stool softeners for adults and paediatrics), Paracetamol Suppositories in four strengths (125mg-1000mg), Amgesic 1% Pain Relief Gel, and Vita-E Range. Products serve therapy areas across dermatology, wound care, topical joint pain, prostate cancer, paediatric pain and fever, respiratory health, and digestive health.
Differentiator
Problem solved
Functional benefit
Products and services
- Carbocisteine Syrup Prescription-only medicine (POM) containing 250mg/5ml carbocisteine, a mucolytic for treating airway problems with excess or thick mucus, including COPD. Used by healthcare professionals and patients for 40 years.
- Diclofenac 1% Gel White smooth homogeneous gel containing diclofenac for topical application, used for mild to moderate muscle pains, bruises, and post-traumatic pain. Prescription-only medicine available in 30g, 60g, and 100g packs.
- Fludroxycortide Tape Topical corticosteroid product for dermatological applications. Prescription-only medicine.
- Nystaform HC Cream Combination cream containing antifungal (nystatin) and antibacterial (chlorhexidine) for treatment of infected dermatoses where fungal and/or bacterial infections are present. Prescription-only medicine.
- Nystaform HC Ointment Combination ointment with antifungal and antibacterial properties for infected skin conditions. Prescription-only medicine.
- Nystaform Cream Light-yellow combination cream containing nystatin (antifungal, 100,000 I.U./g) and chlorhexidine hydrochloride (antibacterial, 1.0% w/w) for treatment of infected dermatoses. Available in 30g pack.
- Docusate Adult Oral Solution Docusate Sodium 50mg/5ml Oral Solution, a P Pharmacy Medicine classified as a laxative for preventing and treating constipation in adults. Clear, almost colourless syrupy liquid with strawberry flavour. Available in 300ml.
- Docusate Paediatric Oral Solution Docusate Sodium Paediatric 12.5mg/5ml Oral Solution, a P Pharmacy Medicine laxative for children aged 6 months to 12 years for preventing and treating constipation.
- Docusol Paediatric Solution Clear oral liquid containing Docusate Sodium 12.5mg in 5ml, a stool softener for preventing and treating constipation in infants over 6 months and children. Available from local pharmacy or online through Chemist4U.
- Docusol Constipation Relief Docusol Constipation Relief 50mg/5ml Solution, a GSL medicine for preventing and treating chronic constipation in adults and children over 12 years. Developed to prevent hard, dry stools and reduce straining. Available in 125ml, purchasable online through Amazon.
- Paracetamol Suppositories P Pharmacy Medicine available in four strengths (125mg, 250mg, 500mg, 1000mg) for treatment of mild to moderate pain and fever when oral medication cannot be taken. Inserted into the rectum.
- Amgesic 1% Pain Relief Gel Anti-inflammatory gel containing diclofenac sodium (NSAID) for relieving pain and reducing inflammation and swelling in joints and muscles. Treats muscle and joint injuries, tendonitis, joint pain. GSL licensed product available in 50g and 100g packs.
- Vita-E Range Vitamin E preparations available in 5 capsule concentrations for dietary supplementation.
- Packpharm Contract Medicine Packaging Full-service medicine packaging manufacturing solutions at MHRA accredited site, packing prescription-only pharmaceuticals, nutritional supplements, and OTC medicines. Holds MIA, MS licenses, WDA(h) and controlled drugs license. Approved by US FDA for US, UK, and EU customers.
- Loyal Pharmacy Community Pharmacy Retail Group of community pharmacies operating in Norfolk and Suffolk, providing retail pharmacy services to local consumers.
Quantifiable outcome
- Docusol has been used by healthcare professionals and patients for 22 years
- +2 more outcomes
Companies that use Typharm
Customer profileNamed customers4 records
Segments1 record
Ideal customer profiles4 records
Typharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Typharm partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- Clinical Commissioning Groups (CCGs)coreBuilt robust network of clinical relationships across the healthcare professional environment over the last 40 years. Working with prescribing advisors and commissioning groups for healthcare product adoption.
- Royal Pharmaceutical Society (RPS)coreWorking relationship with RPS for professional pharmaceutical guidance and industry standards alignment.
- British Dermatological Nursing Group (BDNG)corePartnership enabling understanding of patient and healthcare professional needs for skin and wound care solutions.
- Primary Care Dermatology Society (PCDS)coreCollaboration for primary care dermatology expertise and product development.
- British Association of Dermatologists (BAD)coreProfessional association partnership for dermatological guidance and patient care standards.
- National Eczema Society (NES)minorPartnership for eczema awareness and patient support programs.
- Wounds UKcorePartnership for wound care management solutions and professional education.
- British Society of Gastroenterology (BSG)coreCollaboration for digestive health solutions and gastroenterology expertise.
- British Association of Urological Surgeons (BAUS)minorPartnership for urological surgery insights related to prostate cancer products.
- British Association of Urological Nurses (BAUN)minorPartnership for nursing insights in urological care.
- European Association of Urology (EAU)minorEuropean professional association for urology expertise.
- Healthcare Distribution Association UKcoreDistribution partnership for pharmaceutical product supply chain in UK.
Scale indicators5 records
Recent moves8 records
Expansion highlights6 records
Typharm competitors and assessment
Company assessmentDirect peers
- Thornton & Ross: UK manufacturer of OTC medicines and specialty pharmaceuticals (now part of STADA), offering comparable MHRA-approved manufacturing and consumer healthcare products to Typharm's portfolio.
- Almus Pharmaceuticals: UK supplier of generic pharmaceuticals to pharmacy chains and wholesalers; comparable channel model and product portfolio to Typharm's OTC and prescription generics.
- Martindale Pharma: UK specialty pharma manufacturer focused on hospital and specialty products, including injectables and specials; comparable as a UK-based MHRA-licensed manufacturer serving similar therapeutic areas.
- Dermal Laboratories: UK-based dermatology-focused pharmaceutical manufacturer producing prescription topical products; highly comparable given Typharm's strong dermatology/wound care franchise.
- Alliance Pharmaceuticals: UK-based specialty pharmaceutical company marketing prescription and OTC products across dermatology and consumer health, directly comparable to Typharm's specialty generics and OTC mix.
- Pinewood Healthcare: UK-based manufacturer of generic and OTC pharmaceuticals including liquids and topical dosage forms, directly comparable to Typharm's finished dosage form manufacturing capabilities.
Broad incumbents
- Galderma: Global dermatology-focused pharmaceutical company with branded prescription and OTC skin products; comparable as a dermatology-focused competitor with significantly larger R&D and commercial resources.
- Sandoz: Global leader in generic pharmaceuticals with broad finished dosage form portfolio; relevant incumbent comparable to Typharm but at vastly greater scale across all therapy areas.
- Perrigo Company: Large global OTC consumer healthcare and generics company; comparable on GSL OTC products such as laxatives (Docusate) and topical pain (Diclofenac gel) in Typharm's portfolio.
- Hikma Pharmaceuticals: Large UK-headquartered generics and specialty pharmaceutical manufacturer with broader product portfolio and global reach; comparable as a UK-domiciled generic/OTC manufacturer but operates at materially larger scale.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Typharm social profiles
Digital presenceTypharm compliance and trust
Trust signalCompliance4 records
Typharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Typharm leadership team
Management profileNumber of profiles
Profiles1 record
Typharm subsidiaries and ownership
Company hierarchySubsidiaries4 records
Typharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Typharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Typharm
What does Typharm do?
Typharm is an MHRA-approved pharmaceutical manufacturer that develops, licenses, and supplies prescription-only medicines (POM) and over-the-counter (OTC) medicines across dermatology, wound care, digestive health, fever and pain, anti-inflammation, and respiratory health. Through its subsidiaries (Typharm Limited, Amdeepcha Limited, Packpharm Limited, and Loyal Pharmacy Ltd), the group produces its own branded and generic medicines, provides full-service contract medicine packaging, and operates community pharmacies in the UK with exports to the EU, Middle East, Asia, and the Caribbean.
Is Typharm a public or private company?
Typharm is a private company. It is classified as family owned and is currently operating.
When was Typharm founded?
Typharm was founded in 1966. It employs 101 to 250 people.
Where is Typharm based?
Typharm is headquartered in Norwich, United Kingdom, in the Europe region.
How does Typharm make money?
Four revenue lines are on record. Prescription Medicines are the primary driver. The others are over-the-Counter (OTC) Medicines, manufacturing Services and community Pharmacy.
Who are Typharm's main competitors?
Direct peers on record are Thornton & Ross, Almus Pharmaceuticals, Martindale Pharma, Dermal Laboratories, Alliance Pharmaceuticals and Pinewood Healthcare. Broad incumbents are Galderma, Sandoz, Perrigo Company and Hikma Pharmaceuticals.
Does Typharm have an API?
No public API is recorded for Typharm.
What industry is Typharm in?
Typharm's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAH, Generic Finished Dosage Form (FDF) Manufacturing, with a secondary code of HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO). Its NAICS code is 325412 and its SIC code is 2834.